D.E. Shaw & Co’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.87M Sell
22,300
-26,900
-55% -$5.51M ﹤0.01% 2376
2025
Q4
$12.6M Buy
49,200
+7,200
+17% +$1.89M 0.01% 1548
2025
Q3
$10.9M Sell
42,000
-40,200
-49% -$10.6M 0.01% 1607
2025
Q2
$20.1M Buy
82,200
+39,800
+94% +$9.92M 0.01% 1031
2025
Q1
$11.2M Sell
42,400
-16,500
-28% -$4.46M 0.01% 1304
2024
Q4
$14.9M Buy
58,900
+3,300
+6% +$885K 0.01% 1230
2024
Q3
$17.6M Sell
55,600
-6,100
-10% -$2.17M 0.02% 1066
2024
Q2
$23.1M Buy
61,700
+34,400
+126% +$11.6M 0.02% 819
2024
Q1
$9.47M Buy
27,300
+21,000
+333% +$7.96M 0.01% 1400
2023
Q4
$2.88M Sell
6,300
-3,200
-34% -$1.58M ﹤0.01% 2372
2023
Q3
$4.62M Sell
9,500
-7,200
-43% -$3.38M ﹤0.01% 1878
2023
Q2
$7.47M Buy
+16,700
New +$8.41M 0.01% 1579
2022
Q1
Sell
-50,200
Closed -$23.3M 5712
2021
Q4
$23.3M Sell
50,200
-13,400
-21% -$5.93M 0.02% 985
2021
Q3
$24.8M Buy
63,600
+8,100
+15% +$3.44M 0.02% 886
2021
Q2
$24.6M Buy
55,500
+500
+0.9% +$218K 0.02% 905
2021
Q1
$23.1M Sell
55,000
-25,100
-31% -$10M 0.02% 853
2020
Q4
$32.9M Buy
80,100
+37,300
+87% +$15.5M 0.03% 690
2020
Q3
$17.7M Sell
42,800
-29,900
-41% -$12M 0.02% 900
2020
Q2
$28.2M Buy
72,700
+17,100
+31% +$6.4M 0.03% 603
2020
Q1
$17.5M Buy
55,600
+29,800
+116% +$10.1M 0.03% 696
2019
Q4
$9.46M Buy
25,800
+20,000
+345% +$6.34M 0.01% 1238
2019
Q3
$1.48M Hold
5,800
﹤0.01% 2577
2019
Q2
$1.54M Sell
5,800
-20,000
-78% -$5.07M ﹤0.01% 2418
2019
Q1
$6.86M Sell
25,800
-36,500
-59% -$10.5M 0.01% 1346
2018
Q4
$17.8M Sell
62,300
-10,000
-14% -$3.17M 0.02% 759
2018
Q3
$24.5M Sell
72,300
-20,400
-22% -$6.63M 0.03% 680
2018
Q2
$27.6M Buy
92,700
+15,000
+19% +$4.39M 0.04% 571
2018
Q1
$20.9M Buy
77,700
+30,100
+63% +$8.15M 0.03% 643
2017
Q4
$11.8M Sell
47,600
-50,100
-51% -$12.4M 0.02% 934
2017
Q3
$23.8M Hold
97,700
0.04% 544
2017
Q2
$23.5M Sell
97,700
-20,000
-17% -$4.53M 0.04% 530
2017
Q1
$24.3M Sell
117,700
-49,300
-30% -$10.2M 0.04% 495
2016
Q4
$34.1M Buy
167,000
+60,000
+56% +$11.4M 0.06% 429
2016
Q3
$18.9M Sell
107,000
-53,000
-33% -$9.2M 0.03% 602
2016
Q2
$28.8M Sell
160,000
-210,000
-57% -$37.3M 0.05% 427
2016
Q1
$67.7M Buy
370,000
+207,000
+127% +$35.9M 0.12% 194
2015
Q4
$29.1M Hold
163,000
0.04% 478
2015
Q3
$29.2M Buy
163,000
+100,000
+159% +$18.5M 0.04% 469
2015
Q2
$12.1M Buy
63,000
+5,500
+10% +$1.02M 0.02% 913
2015
Q1
$10.2M Sell
57,500
-93,500
-62% -$14.8M 0.02% 954
2014
Q4
$21.7M Sell
151,000
-6,300
-4% -$861K 0.03% 682
2014
Q3
$20.5M Buy
157,300
+13,000
+9% +$1.65M 0.03% 687
2014
Q2
$18.4M Buy
144,300
+10,000
+7% +$1.18M 0.03% 733
2014
Q1
$15.1M Sell
134,300
-30,300
-18% -$3.16M 0.02% 802
2013
Q4
$17M Buy
164,600
+63,700
+63% +$6.24M 0.02% 782
2013
Q3
$9.42M Buy
100,900
+49,700
+97% +$4.56M 0.02% 1064
2013
Q2
$4.32M Buy
+51,200
New +$4.04M 0.01% 1464

Other funds holding HUM

D.E. Shaw & Co's HUM Position: Q1 2026 in Review

D.E. Shaw & Co increased its Humana (HUM) stake by 22% in Q1 2026, buying an estimated $20.9M and bringing the position to 555,207 shares worth $96.3M. The position accounts for 0.06% of the portfolio, ranked #395.

D.E. Shaw & Co first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $448M in Q1 2016. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • D.E. Shaw & Co held 555,207 shares of Humana worth $96.3M as of Q1 2026.
  • D.E. Shaw & Co bought 101,735 Humana shares in Q1 2026, an estimated $20.9M.
  • Humana made up 0.06% of D.E. Shaw & Co's portfolio in Q1 2026, its #395 holding.
  • D.E. Shaw & Co first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
  • D.E. Shaw & Co's Humana position peaked at $448M in Q1 2016.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.